Back to Network
4
Shared Docs
4
Same-Page
4 / 4
Mentions
Document Mentions (4 shared documents)
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
aria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR and other epigenetic reprogramming factors. Lead by Bobby Dhadwar and Eswar Iyer. Possibly mergeable with 7) A new sequencing method capable of displacing part of the medical pathology imaging market and filling in
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
aria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR and other epigenetic reprogramming factors. Lead by Bobby Dhadwar and Eswar lyer. Possibly mergeable with Supercentenarianstudy.com 7) A new sequencing method capable of displacing part of the medical pathology im
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
aria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR and other epigenetic reprogramming factors. Lead by Bobby Dhadwar and Eswar lyer. Possibly mergeable with Sunercentenarianstudy.com 7) A new sequencing method capable of displacing pan of the medical pathology ima
Sponsored
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
aria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR and other epigenetic reprogramming factors. Lead by Bobby Dhadwar and Eswar lyer. Possibly mergeable with Supereentenarianstudv coin 7) A new sequencing method capable of displacing part of the medical pathology im
Sponsored
Mutual Connections (18)
Entities connected to both Amyris and Bobby Dhadwar
Jeffrey Epstein
PERSON7 w/ Amyris·4 w/ Bobby
Marc Rich
PERSON7 w/ Amyris·4 w/ Bobby
JQ
Justin Quinn
PERSON4 w/ Amyris·4 w/ Bobby
Robert Gates
PERSON4 w/ Amyris·4 w/ Bobby
Justin Trudeau
PERSON4 w/ Amyris·4 w/ Bobby
JC
James Clement
PERSON4 w/ Amyris·4 w/ Bobby
KE
Kevin Esvelt
PERSON4 w/ Amyris·4 w/ Bobby
Space Genetics
ORGANIZATION4 w/ Amyris·4 w/ Bobby
PM
Prashant Mali
PERSON4 w/ Amyris·4 w/ Bobby
DM
Dan Mandell
PERSON4 w/ Amyris·4 w/ Bobby
TW
Ting Wu
PERSON4 w/ Amyris·4 w/ Bobby
RT
Rich Terry
PERSON4 w/ Amyris·4 w/ Bobby
MM
Margo Monroe
PERSON4 w/ Amyris·4 w/ Bobby
the American Bison
ORGANIZATION3 w/ Amyris·3 w/ Bobby
ES
Eswar
PERSON3 w/ Amyris·3 w/ Bobby
LY
Luhan Yang
PERSON3 w/ Amyris·3 w/ Bobby
Eric Trump
PERSON3 w/ Amyris·2 w/ Bobby
HE
Helicos
PERSON2 w/ Amyris·2 w/ Bobby